Erlotinib Completed Phase 1 Trials for Stage III Esophageal Cancer / Malignant Neoplasm of Stomach Stage II / Squamous Cell Carcinoma of the Esophagus / Stage III Gastric Cancer / Adenocarcinoma of the Esophagus / Adenocarcinoma of the Stomach / Adenocarcinomas of the Gastroesophageal Junction / Stage II Esophageal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01561014Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction